Blogs

Novel applications of artemisinin ingredients or composition of artemisinin ingredients in skin care|青蒿素类成分或其组合物在皮肤护理中的新应用

Short Link : https://gettr.ink/APp5Ab The invention relates to novel applications of the defined artemisinin ingredients or a composition of the artemisinin ingredients, namely, the novel applications in the skin care field of mammals. According to the novel applications, the bad state of the skin of the mammals is eliminated or alleviated so that the healthy and beauty of the skin are enhanced through the means of regulating the keratinization disorder, inhibiting hyperpigmentation, resist

July 8

Application of the Artesunate as immunologic adjuvant in preparation rabies vacciness|青蒿琥酯作为免疫佐剂在制备狂犬病疫苗中的应用

The present invention provides application of the Artesunate as immunologic adjuvant in preparation rabies vacciness, and present invention firstly provides artemisinin derivative Artesunate (ART) is used as rabies vacciness adjuvant.The present invention passes through experimental studies have found that artemisinin derivative Artesunate (ART) is as rabies vacciness adjuvant can significantly increase its immunogenicity, can be used as new semple type rabies vaccine candidate adjuvant.The Arte

July 8

Effects and application of artemisinin and its derivative in inhibition of platelet-derived growth factor receptor A|青蒿素及其衍生物在抑制血小板衍生生长因子受体a中的作用及其应用

The invention relates to effects and application of artemisinin and its derivative in inhibition of platelet-derived growth factor receptor A. Particularly, artemisinin and its derivative directly act on a molecular target platelet-derived growth factor receptor A (PDGFR alpha) of a tumor and combines with PDGFR alpha on a cell membrane to inhibit activation of tyrosine kinase at the intracellular domain of PDGFR alpha, inhibit protein stability of PDGFR alpha, and promote a ubiquitin-dependent

July 8

Application of the qinghaosu in the hepatoma Hep G 2 cells drug candidate of preparation treatment EMT activation|青蒿素在制备治疗EMT激活的肝癌HepG2细胞候选药物中的应用

The invention discloses a kind of applications in the hepatoma Hep G 2 cells drug candidate of preparation treatment EMT activation.Qinghaosu has extensive biology and pharmacological action, and wherein effective antitumour effect causes extensive concern in recent years.The mechanism that qinghaosu plays specific anticancer activity is still unclear, this may limit its further development in preclinical and clinical setting.It is inhibited to hepatocellular carcinoma H22 that the present inven

July 8

A kind of combination product and its application for preventing and/or treating cerebral ischemia|一种用于预防和/或治疗脑缺血的组合产品及其应用

The invention belongs to biomedicine technical fields, specifically, being related to a kind of combination product and its application for preventing and/or treating cerebral ischemia.The combination product is the pharmaceutical composition containing Sur1 inhibitor and qinghaosu Sesquiterpene lactones compound；Or the combination for the first medicament containing Sur1 inhibitor and the second medicament containing qinghaosu Sesquiterpene lactones compound.Sur1 inhibitor and qinghaosu Sesquit

July 8

Dihydroartemisinin derivative, medicine and application thereof in preparation of medicine for preventing and treating cerebrovascular diseases|一种双氢青蒿素衍生物、药物及其在制备治疗预防脑血管病药物中的应用

The invention provides a novel dihydroartemisinin derivative, which can be used as an active ingredient to prepare a medicine for preventing and treating ischemic cerebral apoplexy, and the medicine can pass through a blood brain barrier more easily and has higher brain tissue medicine concentration. 本发明提供了一种新的双氢青蒿素衍生物，以该双氢青蒿素衍生物为活性成分可制备成预防、治疗缺血性脑卒中的药物，而且所述药物更容易通过血脑屏障，具有更高的脑组织药物浓度。 Dihydroartemisinin der

July 8

Method for increasing artemisinin content in sweet wormwood by DBR2 (double bond reductase 2) gene transfer|转dbr2基因提高青蒿中青蒿素含量的方法

The invention provides a method for increasing artemisinin content in sweet wormwood by DBR2 (double bond reductase 2) gene transfer in the field of biotechnology. The method includes the steps: cloning genes of artemisinic aldehyde delta 11(13) DBR2 from the sweet wormwood, constructing a plant expression vector containing the DBR2 genes, using agrobacterium tumefaciens for mediation to transfer the DBR2 genes into the sweet wormwood so that plants regenerate, using PCR (polymerase chain reacti

July 8

A method of content of artemisinin in sweet wormwood is improved using AaSPL2 gene|一种利用AaSPL2基因提高青蒿中青蒿素含量的方法

A method of content of artemisinin in sweet wormwood is improved using AaSPL2 gene, include the following steps: to clone salicylic acid signal pathway AaSPL2 gene from sweet wormwood, construct the plant expression vector of the gene containing AaSPL2, with Agrobacterium tumefaciens mediated, AaSPL2 gene is transferred to sweet wormwood and regenerates plant, PCR detects the integration of external source target gene AaSPL2, then measures the content of qinghaosu in transgene abrotanum, and scr

July 8

Haven

Got Cancer? If you've never been vaccinated, you don't have cancer.|癌症？如果从未接种过疫苗，就不会患癌症

The results of a control group survey conducted in the United States in the 2019/2020 period, focusing on individuals who had not received vaccinations nationwide, indicate that those who consistently refuse vaccination are enjoying good health. Meanwhile, those who have received vaccines are experiencing injuries and suffering from various severe harms, including sudden unexpected deaths. This survey quantifies the long-term health risks associated with completely avoiding vaccination and obser

Roger in Haven

June 23

PayMap

全球COVID-19 疫苗接种数据

本文短链接：https://gettr.ink/GAxset 已接种至少一剂 COVID-19 疫苗的总人口百分比 WHO， 2023 年 12 月 31 日国家 % 波多黎各 100% 尼加拉瓜 97% 开曼群岛 95% 古巴 95% 葡萄牙 95% 秘鲁 93% 柬埔寨 92%

Roger in PayMap

June 22

2024年6月11日郭先生庭审的全文中文翻译

本文短链接：gettr.ink/JNSKWF 2021年 O6BBGUO1 美国南区地方法院 ------------------------------x 美利坚合众国对郭文贵（MILES GUO), 被告。 ------------------------------x 纽约,纽约 2024年6月11日上午9:02 出席人员: 阿娜丽莎·托雷斯法官以及陪审团出庭者法庭案件中的法律代表，表格标题如下：法庭案件中的法律代表，以下是列出的内容：代表：无角色：无法庭案件中的法律代表代表人角色达米安·威廉姆斯美国纽约南区检察官

June 11

2024年6月10日郭先生庭审的全文中文翻译

本文短链接：gettr.ink/a8EP8K 美利坚合众国地方法院纽约南区美利坚合众国诉郭江涛被告审判纽约市 2024年6月10日上午9:02 出庭人员：阿娜丽萨·托雷斯法官和陪审团 - 涉及纽约南区法庭法律案件的律师名单，具有以下表格标题：案件中涉及的律师，有以下列：姓名：案件中律师的姓名及所属机构。案件中涉及的律师名单-纽约南区法院, 姓名在案中的所属单位达米安·威廉姆斯(DAMIAN WILLIAMS) 美国纽约南区联邦检察官麦卡·F·费根森(MICAH F. FER

June 11

Artemisia annua

Chapter 4 Efficient Cultivation Techniques for Artemisia annua｜第四章黄花蒿的高效栽培技术

Short Link|短链接：gettr.ink/WNbRtQ Chapter 4 Efficient Cultivation Techniques for Artemisia annua The research and application of standardized cultivation techniques for traditional Chinese medicinal materials are the foundation and prerequisite for ensuring reliable quality, stable efficacy, and safe use of these materials. The study of cultivation techniques for medicinal materials involves systematically understanding their growth and development patterns and then artificially a

Roger in Artemisia annua

June 10

2024年6月7日郭先生庭审的全文中文翻译

本文短链接：gettr.ink/ZfQCF8 2024年6月7日美国纽约南区联邦法院美利坚合众国诉郭文贵被告审判纽约市上午8:45 出庭人员：荣誉法官安娜丽莎·托雷斯，地方法官 -和一名陪审团- END_of_TEXT 法庭案件中的法律代表，以下是表格标题：法庭案件中的法律代表，以下是列标题：代表: 无角色: 无法庭案件中的法律代表代表人角色达米安·威廉斯美国纽约南区检察官代表人: 米卡·F·费根森莱恩·B·

June 8

Haven

《避风港HAVEN》直播内容精选（第八十六集）

摘要：对刺突蛋白的详细研究显示了其导致不良副作用的机制。对刺突蛋白的详细研究显示了其导致不良副作用的机制＂研究性疫苗＂是这种刺突的代号，疫苗接种后的身体在制造它，并不停留于肌肉中，而会在体内循环数周，持续存在至少60天。强生和阿斯利康的腺病毒载体疫苗注入人体这些刺突蛋白DNA后，使人体产生刺突蛋白。辉瑞和莫德纳的信使核糖核酸疫苗，通过”信息“传输到人体，并产生刺突蛋白。所有新冠疫苗都会产生像红芽般的刺突蛋白。这些红芽般的刺突蛋白和武汉原株是同等的。新冠疫苗实际是这种新冠病毒致命的部分。新冠疫苗是人类造出的最有危害性的疫苗。因为新冠疫苗是完全不受控的。新冠疫苗提供基因代码产生的刺突蛋白既无时间段控制，也无数量控制。所以，人体在很长一段时间内都会生产不受控的过量刺突蛋白，那就会致命。病案与分享1)， 8月7号晚上突感身体不适，背部，腿部酸胀

Roger in Haven

June 8

Haven

《避风港Haven》直播内容精选（第八十四期）

Dr.Kelly Victory说，在上周与参议员罗恩·约翰逊的听证会后得知一件很重要的信息，是由三名职业军医发布的医疗数据。他们从军事数据库中收集到的ICD代码得到的信息，也是我们所说的诊断代码。他们为2016-2020的5年段的情况改变联络了军事数据库（别忘了2020年还是新冠疫情的一年）。他们查看了2016, 17, 18, 19, 和20年的疾病普遍率，包括心脏病发作、肺部的血栓和流产。他们将2021年与之前五年的同样发病率作比较，看到了某些疾病诊断的惊人的增长。例如，他们看到**2021年心肌梗塞增加了270%。贝尔氏面瘫和某些神经系统疾病的发病率增加了300%。肺栓塞和肺部血栓增加了470%。** 军医们还发现了许多其他疾病的百分比增加，没有人能确定这些症状是怎样发生的，但作为科学家们，不能疏忽这些事实。到底2021年发生的什么，使得这一年与之前5年的平均数据大不一样，

Roger in Haven

June 8

2024年6月6日郭先生庭审的全文中文翻译

本文短链接：gettr.ink/eHrzDZ 美利坚合众国纽约南区联邦地方法院美利坚合众国诉郭文贵被告审判纽约市 2024年6月6日上午8:45 在场人员：阿娜丽莎·托雷斯法官和陪审团 - 出庭者法庭案件中的法律代表表格标题：法庭案件中的法律代表列名：代表：涉及法庭案件的法律代表的姓名法庭案件中的法律代表代表法庭案件涉及的法律代表姓名 DAMIAN WILLIAMS 美国纽约南区联邦检察官由：MICAH F. FERGENSON

June 6

2024年6月5日郭先生庭审的全文中文翻译

注：以下文本为ChatGPT AI翻译，未经人工校对，仅供参考！请以2024年6月5号郭先生庭审英文文字笔录为准。本文短链接：gettr.ink/nihrjF 美利坚合众国地方法院纽约南区 ------------------------------x 美利坚合众国，诉 23 Cr. 118 (AT) 郭文贵，被告。审判 ------------------------------x 纽约市 2024年6月5日上午9:05 在座： ANALISA TORRES女士，地方法官 -及陪审团- 出庭人员涉及纽约南区法院法律案件的律师名单，表格标题：案件涉及的律师列标题：姓名：涉及的律师姓名角色：每位律师在案件中的角色南纽约联邦地区法院涉案律师名单名称

June 6

2024年6月4日郭先生庭审的全文中文翻译

本文短链接：gettr.ink/iccHe7 2024年6月4号郭先生庭审英文文字笔录: https://nfsc.press/wp-content/uploads/2024/06/Case-23_cr_00118_Transcript-04-06-2024.pdf （注：未经人工校对，仅供参考！）的中文AI翻译全文如下：美利坚合众国地方法院纽约南区 ------------------------------x 美利坚合众国，告变人，郭万里，被告人。 ------------------------------x 2024年6月4日纽约市上午9:00 出庭：控方代理人辩方代理人法官：托雷斯法官，地方法官 -和陪审团- 译者注：以上为法庭文件中的部分内容。法庭案件中的法律代表，以下是表格标题：法庭案件中的法律